87 related articles for article (PubMed ID: 28843270)
1. Clinicopathological Impact of FOXM1 and MMP-9 Immunohistochemical Expression in Different Grades of Intracranial Meningioma.
Ibrahim HM; Abdelrahman AE; Elwan A; Gharieb SA; Refaat M; Elmesallamy W; Salem AA
Appl Immunohistochem Mol Morphol; 2024 Jun; ():. PubMed ID: 38863278
[TBL] [Abstract][Full Text] [Related]
2. CD44 Expression in Meningioma and its Correlation with Proliferation Indices.
Mostafa RR; Khairy RA
J Clin Diagn Res; 2017 Aug; 11(8):EC12-EC15. PubMed ID: 28969134
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the status of immune checkpoint molecules in meningiomas by immunohistochemistry.
Saygin I; Cakir E; Kazaz SN; Guvercin AR; Eyuboglu I; Ustaoglu MM
Turk Neurosurg; 2023 Aug; ():. PubMed ID: 38874241
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 2 serves as a pathogenic hub gene of KRAS mutant colon cancer based on integrated analysis.
Peng WB; Li YP; Zeng Y; Chen K
World J Gastrointest Oncol; 2024 May; 16(5):2074-2090. PubMed ID: 38764826
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Meningioma Immunogenetics.
Al-Rashed M; Foshay K; Abedalthagafi M
Front Oncol; 2019; 9():1472. PubMed ID: 31970090
[TBL] [Abstract][Full Text] [Related]
6. Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Oberheim Bush NA; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
Cancer Discov; 2024 May; ():. PubMed ID: 38742767
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments.
Mahmoudian E; Khalilnezhad A; Gharagozli K; Amani D
Gene; 2017 Nov; 634():29-36. PubMed ID: 28844667
[TBL] [Abstract][Full Text] [Related]
8. Immune cell infiltration and inflammatory landscape in primary brain tumours.
Luce A; Abate M; Scognamiglio G; Montella M; Iervolino D; Campione S; Di Mauro A; Sepe O; Gigantino V; Tathode MS; Ferrara G; Monaco R; De Dominicis G; Misso G; Gentile V; Franco R; Zappavigna S; Caraglia M
J Transl Med; 2024 May; 22(1):521. PubMed ID: 38816839
[TBL] [Abstract][Full Text] [Related]
9. Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.
Buccarelli M; Castellani G; Fiorentino V; Pizzimenti C; Beninati S; Ricci-Vitiani L; Scattoni ML; Mischiati C; Facchiano F; Tabolacci C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667282
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers.
Chen Y; Ning J; Cao W; Wang S; Du T; Jiang J; Feng X; Zhang B
Front Oncol; 2020; 10():568574. PubMed ID: 33194655
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.
Eckert RL
Mol Carcinog; 2019 Jun; 58(6):837-853. PubMed ID: 30693974
[TBL] [Abstract][Full Text] [Related]
12. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
[TBL] [Abstract][Full Text] [Related]
13. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
14. Classification of human meningiomas: lights, shadows, and future perspectives.
Barresi V; Caffo M; Tuccari G
J Neurosci Res; 2016 Dec; 94(12):1604-1612. PubMed ID: 27376782
[TBL] [Abstract][Full Text] [Related]
15. Basis for Immunotherapy for Treatment of Meningiomas.
Garzon-Muvdi T; Bailey DD; Pernik MN; Pan E
Front Neurol; 2020; 11():945. PubMed ID: 32982948
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin-Interact ing-Pro t e in [TXNIP] and Transglutaminase 2 [TGM2] Expression in Meningiomas of Different Grades and the Role of Their Expression in Meningioma Recurrence and Prognosis.
Harb OA; Elsayed WS; Ismail EI; Toam MM; Ammar MG
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2299-2308. PubMed ID: 28843270
[TBL] [Abstract][Full Text] [Related]
17. Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.
Cai Z; Zhang C; Zou Y; Lu C; Hu H; Qian J; Jiang L; Hu G
Int J Clin Oncol; 2017 Aug; 22(4):660-666. PubMed ID: 28243945
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
